Stay updated on Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:31:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-04-24T01:35:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about the clinical trial for Plasma Cell Myeloma, including the involvement of the National Cancer Institute and a revision update. However, significant details regarding the trial's objectives and procedures have been removed.
    Difference
    49%
    Check dated 2025-04-16T20:40:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    1%
    Check dated 2025-04-09T14:56:07.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:20:10.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-03-11T08:42:28.000Z thumbnail image

Stay in the know with updates to Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.